Ahmadi, Moosavi, Hosseinpour Feizi,
Volume 13, Issue 3 (9-2010)
Abstract
Background: Recently, reports have been made of the effects of boric acid (BA) on cancer prevention and inhibition of cancer cell proliferation. This study was designed to investigate the effects of this compound on K562 cell line as a model of chronic myeloid leukemia (CML). Materials and Methods: In this experimental trial, K562 cell line was cultured in the presence of 0.75 to 12 mmol concentrations of boric acid for 24, 48, 72, and 96 hour intervals. Anti-proliferative and cytotoxic effects of BA were measured by trypan blue exclusion test and MTT assay, respectively. Flow-cytometery was utilized for evaluating the effects of BA on cell cycle. Wright-giemsa staining was used for determining the effects of BA, and latex phagocytic assay was used for evaluating the phagocytic potential of the differentiated cells. Results: BA induced growth inhibition of K562 cells in a dose and time dependent manner after 96 hours of treatment with 12 mmol BA, cell proliferation of K562 cells was inhibited to about 83% (p<0.001). In addition, BA induced G1 cell cycle arrest in a way that for instance, after 6 days of treatment with 9 mmol BA, 98% of cell populations were at G1 level. Wright-giemsa staining and latex phagocytic assay results confirmed that K562 cells differentiated toward monocyte-macrophage lineage. Conclusion: Noticing the anti-proliferative and differentiating effects of BA, and no evidence of its adverse effects, this compound can be used as alone or in combination with other drugs in CML differentiation therapy.
Mohsen Khaki, Hamid Abtahi, Ghasem Mosayebi,
Volume 22, Issue 6 (1-2020)
Abstract
Background and Aim: The most important problem in the production of recombinant proteins in prokaryotic cells is the disruption of the function of these proteins due to their altered natural structure. The aim of present study is to identify the best chemicals dialysis buffer additives in order to improve the protein structure of recombinant Vascular Endothelial Growth Factor (VEGF)
Methods & Materials: In this experimental study, different chemicals additives were selected using relevant software. After adding these additives to the recombinant VEGF dialysis buffer, their effect on the refolding of recombinant proteins and the differentiation of mesenchymal stem cells into endothelial cells was assessed by flow cytometry method.
Ethical Considerations: This study obtained its ethical approval from the Research Ethics Committee of Arak University of Medical Sciences (Code: ARAKMU. REC.1394.199).
Results: The results showed that the addition of arginine, cysteine and dithiothreitol (DTT) to dialysis buffer increases the differentiation of mesenchymal stem cells into endothelial cells. With the presence of sodium chloride (NaCl), cysteine, arginine and DTT in treated cells, the rate of specific Cluster Differentiation (CD) markers of endothelial cell (CD31/144) was at the highest level.
Conclusion: Adding cysteine, arginine, DTT and NaCl to the dialysis buffer of recombinant VEGF had the greatest effect on the mesenchymal cell differentiation into endothelial cells.
